Changes in PRMT4, mainly upregulation, are frequently reported in various types of human cancers, including breast cancer 18, lung cancer 17, colorectal cancer 19, and prostate cancer 20, which appears to promote cancer initiation, progression and metastasis. Here, CARM1 is linked to lung carcinoma.